Hikma Pharmaceuticals Plc Result of AGM

Data : 17/05/2019 @ 17:09
Fonte : UK Regulatory (RNS & others)
Titolo : Hikma Pharmaceuticals Plc (HIK)
Quotazione : 1904.5  -23.0 (-1.19%) @ 09:23
Quotazione Hikma Pharmaceuticals Grafico

Hikma Pharmaceuticals Plc Result of AGM

Grafico Azioni Hikma Pharmaceuticals (LSE:HIK)
Storico

1 Anno : Da Feb 2019 a Feb 2020

Clicca qui per i Grafici di Hikma Pharmaceuticals

TIDMHIK

RNS Number : 4627Z

Hikma Pharmaceuticals Plc

17 May 2019

Hikma Pharmaceuticals PLC

Voting Results of 2019 Annual General Meeting

LONDON, 17 May 2019 - Hikma Pharmaceuticals PLC (the "Company") announces its Annual General Meeting ("AGM"), held at Sofitel St James, 6 Waterloo Place, London SW1Y 4AN on 17 May 2019 commenced at 10:00 am. All resolutions were duly passed by shareholders by way of a poll. Resolutions 1 to 16 were passed as ordinary resolutions and Resolutions 17 to 20 were passed as special resolutions.

Copies of the resolutions dealing with special business passed at the AGM have been submitted to the National Storage Mechanism and will shortly be available for inspection at www.morningstar.co.uk/uk/nsm

The total number of votes cast on the poll for each resolution (the full text of the resolutions is detailed in the notice of the AGM dated 15 April 2019) is set out below. The number of Ordinary Shares in issue on 17 May 2019 was 242,013,996.

 
        Resolution            Votes For      %      Votes Against     %     Total Cast    Withheld 
 1. To receive the 
  2018 report and 
  accounts                   198,016,257    99.99          15,248    0.01   198,031,505    145,325 
                            ------------  -------  --------------  ------  ------------  --------- 
 2. To approve a 
  final dividend of 
  26 cents per share         198,172,485   100.00             437    0.00   198,172,922      3,909 
                            ------------  -------  --------------  ------  ------------  --------- 
 3. To re-appoint 
  PricewaterhouseCoopers 
  LLP as auditors            198,168,429   100.00           2,171    0.00   198,170,600      6,231 
                            ------------  -------  --------------  ------  ------------  --------- 
 4.To authorise the 
  Audit Committee 
  to determine the 
  auditors' remuneration     198,169,496   100.00           1,989    0.00   198,171,485      5,346 
                            ------------  -------  --------------  ------  ------------  --------- 
 5. To re-elect Said 
  Darwazah as a director     191,458,492    96.61       6,712,792    3.39   198,171,284      5,546 
                            ------------  -------  --------------  ------  ------------  --------- 
 6. To re-elect Siggi 
  Olafsson as a director     194,921,594    98.36       3,251,178    1.64   198,172,772      4,059 
                            ------------  -------  --------------  ------  ------------  --------- 
 7. To re-elect Mazen 
  Darwazah as a director     191,501,356    96.63       6,670,679    3.37   198,172,035      4,796 
                            ------------  -------  --------------  ------  ------------  --------- 
 8. To re-elect Robert 
  Pickering as a director    186,397,645    94.06      11,763,463    5.94   198,161,108     15,722 
                            ------------  -------  --------------  ------  ------------  --------- 
 9.To re-elect Ali 
  Al-Husry as a director     189,606,735    95.68       8,564,549    4.32   198,171,284      5,546 
                            ------------  -------  --------------  ------  ------------  --------- 
 10. To re-elect 
  Patrick Butler as 
  a director                 194,287,800    98.04       3,883,484    1.96   198,171,284      5,546 
                            ------------  -------  --------------  ------  ------------  --------- 
 11. To re-elect 
  Dr. Pamela Kirby 
  as a director              182,139,906    91.91      16,032,128    8.09   198,172,034      4,796 
                            ------------  -------  --------------  ------  ------------  --------- 
 12. To re-elect 
  Dr. Jochen Gann 
  as a director              194,395,430    98.09       3,775,854    1.91   198,171,284      5,546 
                            ------------  -------  --------------  ------  ------------  --------- 
 13. To re-elect 
  John Castellani 
  as a director              195,035,397    98.42       3,135,888    1.58   198,171,285      5,546 
                            ------------  -------  --------------  ------  ------------  --------- 
 14. To re-elect 
  Nina Henderson as 
  a director                 194,490,204    98.14       3,681,830    1.86   198,172,034      4,796 
                            ------------  -------  --------------  ------  ------------  --------- 
 15. To approve the 
  remuneration report 
  for the year ended 
  31 December 2018           190,476,075    96.12       7,695,409    3.88   198,171,484      5,346 
                            ------------  -------  --------------  ------  ------------  --------- 
 16. Authority to 
  allot shares               168,835,150    85.20      29,337,771   14.80   198,172,921      3,909 
                            ------------  -------  --------------  ------  ------------  --------- 
 17. To dis-apply 
  pre-emption rights 
  for general purposes       198,116,024    99.97          56,161    0.03   198,172,185      4,646 
                            ------------  -------  --------------  ------  ------------  --------- 
 18. To dis-apply 
  pre-emption rights 
  for an acquisition 
  or other capital 
  investment                 195,242,802    98.52       2,929,382    1.48   198,172,184      4,646 
                            ------------  -------  --------------  ------  ------------  --------- 
 19. To authorise 
  the Company to purchase 
  its own shares             197,396,007    99.66         682,740    0.34   198,078,747     98,083 
                            ------------  -------  --------------  ------  ------------  --------- 
 20. To authorise 
  the Company to hold 
  general meetings 
  on no less than 
  14 clear days' notice      187,234,093    94.48      10,936,803    5.52   198,170,896      5,785 
                            ------------  -------  --------------  ------  ------------  --------- 
 

Declaration of final dividend

The dividend of 26 cents per share will be paid on 22 May 2019 to shareholders on the register on 5 April 2019. Shareholders who are not resident in Jordan have been given the option of receiving their dividend in Pounds Sterling. The exchange rate in respect of this dividend will be $1.2928 to GBP1. The exchange rate for Jordanian Dinar is fixed to the US Dollar at circa 1JD to $1.41.

- ENDS -

Enquiries:

 
 Hikma Pharmaceuticals PLC 
 Peter Speirs 
  Company Secretary                             +44 20 7399 2670 
 Susan Ringdal 
  EVP, Strategic Planning and Global Affairs    +44 20 7399 2670 
 

About Hikma

Hikma helps put better health within reach every day for millions of people in more than 50 countries around the world. For 40 years, we've been creating high-quality medicines and making them accessible to the people who need them. We're a global company with a local presence across the United States (US), the Middle East and North Africa (MENA) and Europe, and we use our unique insight and expertise to transform cutting-edge science into innovative solutions that transform people's lives. We're committed to our customers, and the people they care for, and by thinking creatively and acting practically, we provide them with a broad range of branded and non-branded generic medicines. Together, our 8,500 colleagues are helping to shape a healthier world that enriches all our communities. We are a leading licensing partner in the MENA region, and through our venture capital arm, are helping bring innovative health technologies to people around the world. For more information, please visit www.hikma.com.

LEI: 549300BNS685UXH4JI75

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

RAGSFWFIWFUSESI

(END) Dow Jones Newswires

May 17, 2019 11:09 ET (15:09 GMT)

La tua Cronologia
BIT
BMPS
Monte Pasc..
BITI
FTSEMIB
FTSE Mib
BIT
UCG
Unicredit
NASDAQ
AAPL
Apple
FX
EURUSD
Euro vs Do..
Le azioni che visualizzerai appariranno in questo riquadro, così potrai facilmente tornare alle quotazioni di tuo interesse.

Registrati ora per creare la tua watchlist personalizzata in tempo reale streaming.

Per accedere al tempo reale push di Borsa è necessario registrarsi.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

P: V:it D:20200224 08:38:11